Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
SGHT Sight Sciences Inc
- Stocks
- Healthcare
- NASDAQ: SGHT
Price (delayed)
$3.55
Market cap
$183.54M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.99
Enterprise value
$114.36M
Highlights
Sight Sciences's EPS has increased by 12% YoY and by 3.9% from the previous quarter
The net income has grown by 10% YoY and by 4.1% from the previous quarter
The quick ratio has contracted by 20% YoY but it has grown by 15% from the previous quarter
Sight Sciences's equity has decreased by 29% YoY and by 11% QoQ
SGHT's debt is up by 17% year-on-year
Key stats
What are the main financial stats of SGHT
Market
Valuations
Earnings
Shares outstanding
51.7M
Market cap
$183.54M
Enterprise value
$114.36M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.35
Price to sales (P/S)
2.33
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.46
Revenue
$78.11M
Gross profit
$66.91M
Operating income
-$49.67M
Net income
-$49.4M
EBIT
-$44.42M
EBITDA
-$43.14M
Free cash flow
-$24.44M
Per share
Balance sheet
Liquidity
EPS
-$0.99
EPS diluted
-$0.99
Free cash flow per share
-$0.48
Book value per share
$1.51
Revenue per share
$1.52
TBVPS
$2.53
Total assets
$129.68M
Total liabilities
$52.05M
Debt
$39.58M
Equity
$77.63M
Working capital
$114.78M
Debt to equity
0.51
Current ratio
10.47
Quick ratio
9.75
Net debt/EBITDA
1.6
Margins
Efficiency
Dividend
EBITDA margin
-55.2%
Gross margin
85.7%
Net margin
-63.2%
Operating margin
-63.6%
Return on assets
-34.9%
Return on equity
-54.6%
Return on invested capital
-92.5%
Return on capital employed
-37.8%
Return on sales
-56.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SGHT stock price
How has the Sight Sciences stock price performed over time
Intraday
3.8%
1 week
15.26%
1 month
36.02%
1 year
-38.9%
YTD
-2.47%
QTD
47.92%
Financial performance
How have Sight Sciences's revenue and profit performed over time
Revenue
$78.11M
Gross profit
$66.91M
Operating income
-$49.67M
Net income
-$49.4M
Gross margin
85.7%
Net margin
-63.2%
The net income has grown by 10% YoY and by 4.1% from the previous quarter
SGHT's operating income is up by 9% year-on-year
SGHT's net margin is up by 6% year-on-year and by 2% since the previous quarter
The operating margin is up by 4.8% year-on-year
Price vs fundamentals
How does SGHT's price correlate with its fundamentals
Growth
What is Sight Sciences's growth rate over time
Valuation
What is Sight Sciences stock price valuation
P/E
N/A
P/B
2.35
P/S
2.33
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.46
Sight Sciences's EPS has increased by 12% YoY and by 3.9% from the previous quarter
Sight Sciences's equity has decreased by 29% YoY and by 11% QoQ
The stock's P/B is 10% less than its last 4 quarters average of 2.6
The stock's price to sales (P/S) is 22% less than its last 4 quarters average of 3.0
The revenue is down by 4.2% YoY and by 2.2% from the previous quarter
Efficiency
How efficient is Sight Sciences business performance
The company's return on equity fell by 23% YoY and by 4.2% QoQ
The ROA is down by 9% year-on-year
Sight Sciences's ROS has increased by 6% YoY and by 2.6% from the previous quarter
The company's return on invested capital rose by 5% YoY and by 3.7% QoQ
Dividends
What is SGHT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SGHT.
Financial health
How did Sight Sciences financials performed over time
The total assets is 149% more than the total liabilities
The quick ratio has contracted by 20% YoY but it has grown by 15% from the previous quarter
Sight Sciences's current ratio has decreased by 20% YoY but it has increased by 16% QoQ
SGHT's debt is 49% smaller than its equity
SGHT's debt to equity has surged by 65% year-on-year and by 13% since the previous quarter
Sight Sciences's equity has decreased by 29% YoY and by 11% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.